STOCKS TELEGRAPH

Category: Mid Day Movers

What’s Driving The Upward Trend In MDC Holdings Stock?

Shares of M.D.C. Holdings, Inc. (NYSE: MDC) are rising sharply on the US charts this morning. The MDC stock rose 18.21% to $62.76 according to the most recent check during the current session. An announcement of an acquisition deal earlier today is directly responsible for the recent increase in MDC shares.

A formal pact has been disclosed between M.D.C. Holdings (MDC) and Sekisui House, Ltd., a renowned Japanese housing manufacturer. In accordance with the terms of this accord, MDC is set to be acquired through an all-cash transaction orchestrated by a wholly-owned subsidiary of Sekisui House, pegging the equity valuation at US$4.9 billion.

The stipulations of the agreement specify that MDC stockholders will receive US$63.00 in cash for each share. This sum constitutes a noteworthy 41% premium over MDC’s 90-day volume-weighted average trading price and signifies an approximate 19% premium over the closing stock price on January 17, 2024—the conclusive trading day prior to the announcement of the deal.

Using the technological know-how and innovative building techniques that Sekisui House pioneered in Japan, MDC hopes to produce homes of the highest caliber and establish its leadership in important operational states. With this calculated action, Sekisui House hopes to further its global vision of “making home the happiest place in the world.”

Sekisui House will become a part of the Woodside Homes, Holt Homes, Chesmar Homes, and Hubble Homes family of companies after closing, making it the fifth-largest housebuilder in the United States (based on the number of houses finished in 2022). Sekisui House aims to construct 10,000 residences beyond Japan by FY2025, accelerating the achievement of their goal.

Having a history surpassing 50 years, MDC consistently upholds a commitment to excellence, a key factor in its enduring triumph. This dedication generates prosperity for shareholders and also serves the interests of clients, employees, and business allies. With a track record of erecting over 240,000 dwellings, MDC has risen to prominence as a premier homebuilder in the nation.

Its strategic proficiency is evident in its adept navigation of various housing market fluctuations, showcasing corporate resilience. MDC’s constant commitment on enhancing shareholder value and producing significant cash flows for its shareholders is demonstrated by the company’s decision to combine with Sekisui House.

January 18, 2024
What Is Causing An Upswing In Agrify (AGFY) Stock Today?

A surge of 30.51% in Agrify Corporation (NASDAQ: AGFY) stock was observed this morning, reaching $1.54 as of the last check during the current session. This upswing in Agrify shares on the US stock charts is attributable to a recently announced strategic initiative.

Agrify (AGFY) disclosed today that it has forged a substantial sales agreement, valued in the multi-million-dollar range, with Ocean Deep/Golden Lake Business Park, a vertically integrated cannabis operator based in California. Ocean Deep intends to utilize Agrify’s turnkey PX30 Hydrocarbon Extraction Lab Package to enhance its product lineup by extracting various products.

Furthermore, Ocean Deep plans to commence operations with 120 Vertical Farming Units (“VFUs”) provided by Agrify, with the aim of producing premium cannabis flower in 2024. The PX30 Hydrocarbon Extraction System stands out as the largest system among Agrify’s PX-series. Featuring four material columns each weighing 7.5 lbs., the PX30 can operate in parallel, completing a full 30-pound batch cycle in under 60 minutes.

This positions it as one of the most substantial and rapid extractors available, capable of processing up to 240+ lbs. within an 8-hour shift. The PX30 is specifically designed to meet the demands of commercial operators engaged in large-scale batch processing for the creation of direct-to-consumer products. This significant agreement represents AGFY’s first sale of a combined VFU and PX30 Hydrocarbon Extraction Lab facility in California.

The collaboration with Ocean Deep/Golden Lake Business Park reflects the strategic foresight of selecting Agrify’s technologies in the fiercely competitive California market. Agrify anticipates that its advanced cultivation and extraction technologies will empower Ocean Deep to deliver the utmost quality and consistency in its product offerings.

Agrify’s inclusion of UL-compliant Explosion Proof (EXP) Rooms was a deliberate and optimal choice for Ocean Deep’s C1D1 extraction lab. These rooms, designed for safety and ease of installation, adhere to C1D1/C1D2 standards and can be set up in less than a day.

Equipped with a PSI technical report certification, these rooms are approved for professional engineers to verify in all 50 states. These developments underscore the ongoing commitment to innovation and safety within the cannabis sector, as Agrify adapts to the evolving demands of the expanding market.

January 18, 2024
Why Is Sinclair (SBGI) Stock Buzzing Today?

Sinclair, Inc. (NASDAQ: SBGI) is experiencing a surge in its stock performance on the US market today, with shares rising by an impressive 12.78% to reach $15.36 in the current session. The upward trajectory in SBGI stock is coming on the heels of significant developments.

Sinclair (SBGI) in a joint announcement with FOX Corporation unveiled that their broadcast divisions have successfully negotiated a multi-year renewal for all FOX affiliations in Sinclair markets. The renewal extends to markets where Sinclair provides sales and other services under joint sales agreements or master service agreements. This comprehensive agreement encompasses 41 markets, collectively catering to approximately 19 million TV households.

Of particular note is the early renewal of affiliations in 17 markets. In an era where premier sports, such as the NFL, Super Bowl, Baseball Night in America, the World Series, and college football and basketball, hold heightened significance, Sinclair’s ability to continue pairing FOX’s exclusive sports and entertainment programming with top-notch local news and syndicated content is solidified for the foreseeable future.

Simultaneously, Sinclair announced its commitment to a global settlement, pending definitive documentation and final court approval, regarding the litigation filed by Diamond Sports Group, LLC (DSG) and its subsidiary, Diamond Sports Net, LLC, in July 2023. The settlement terms involve the withdrawal of DSG’s $1.5 billion litigation against Sinclair and all other defendants.

In exchange for this withdrawal, Sinclair will make a cash payment of $495 million to DSG. After factoring in corresponding tax benefits, additional Management Services Agreement payments to Sinclair Television Group, LLC (STG), and other assets received in connection with the settlement, Sinclair anticipates a net cost ranging from $250-325 million.

This cash payment will be funded through cash on hand at Sinclair Ventures, LLC, Sinclair Television Group, LLC, and/or a loan backed by Sinclair Ventures, LLC. As part of the settlement, Sinclair has committed to providing transition services to DSG, facilitating its evolution into a self-standing entity moving forward.

January 17, 2024
What Is Propelling A Surge In Safety Shot (SHOT) Stock?

Safety Shot, Inc. (NASDAQ: SHOT) is currently making notable strides in the US financial landscape. As of the last check in current trading session, the value of Safety Shot stock has surged by an impressive 27.93%, reaching $2.29. This upward trajectory can be attributed to significant legal developments favoring the company.

On December 5, 2023, Safety Shot (SHOT) initiated legal proceedings by filing a federal lawsuit in the United States District Court for the Southern District of New York. The lawsuit was directed against Capybara Research, an entity purportedly established to impart “credibility” to malicious and defamatory articles.

These articles, intentionally designed to detrimentally affect the stock prices of publicly traded companies, were allegedly orchestrated by Capybara Research. The lawsuit also targeted the previously anonymous owner and operator responsible for a particularly damaging article published on November 22, 2023. This article resulted in a staggering 37.03% decline in Safety Shot’s share price.

Following the commencement of legal action, SHOT’s legal representatives at The Basile Law Firm, P.C. unveiled the true identity of the individual behind the defamatory article—Brazilian resident Igor Appelboom. Appelboom, who previously operated under his own name on X (formerly known as Twitter), engaged in content related to the short selling of securities.

Capybara Research and Appelboom allegedly engage in short selling and release misleading reports to deliberately drive down stock prices for personal gain. Safety Shot perceives this conduct as potentially criminal and remains steadfast in safeguarding the interests of its shareholders. In response to the evasive actions taken by Capybara and Appelboom to avoid service, SHOT filed a motion on December 22, 2023, seeking alternative methods such as email service.

Subsequently, on January 10, 2024, a historic ruling by The Honorable Judge granted permission for the company to serve notice of the legal action through a press release—an unprecedented and groundbreaking approach. This innovative legal maneuver signifies Safety Shot’s commitment to pursuing justice despite attempts to obstruct due process.

January 17, 2024
Bullfrog AI (BFRG) Stock Surges On Revolutionary Findings

The US stock market has witnessed a noteworthy upsurge in BullFrog AI Holdings, Inc. (NASDAQ: BFRG), with the company seeing an incredible 26.70% current-session spike to reach $3.345. This upsurge is credited to a ground-breaking partnership between BullFrog AI and the Lieber Institute for Brain Development (LIBD), which unveiled preliminary findings that might fundamentally alter the understanding and management of mental illnesses.

BullFrog AI (BFRG) has officially unveiled the preliminary outcomes arising from its collaboration with LIBD, a partnership poised to reshape the landscape of psychiatric research. Employing BullFrog’s bfLEAP platform on LIBD’s extensive brain data has successfully stratified brain expression data, offering unparalleled insights into the intricate nature of psychiatric conditions.

With BullFrog AI’s access to LIBD’s unmatched brain data, this partnership marks a turning point in the field of psychiatric research as it advances our understanding of the intricate biological underpinnings of mental illnesses. Not only do these results improve BFRG’s understanding of these illnesses, but they also pave the way for profitable strategic alliances with pharmaceutical firms that have the potential to provide significant profits.

The exclusive LIBD data set includes gene expression information from an astounding 2,800 brain samples, including major depressive disorder, bipolar disorder, schizophrenia, and non-psychiatric control brains. Leveraging graph analytics, BullFrog AI and LIBD have achieved a groundbreaking feat by clustering subjects solely based on biological data, revealing distinct differences and similarities in biological pathways across various brain disorders.

The market potential for new treatments in psychiatric disorders is vast and underserved. The collaboration between BullFrog AI and LIBD, with its innovative approach and promising early findings, presents a potential paradigm shift in treatment strategies. Identifying biological subtypes within disorders not only advances scientific understanding but also opens avenues for novel therapeutic approaches and personalized treatment strategies, addressing the increasing global demand for mental health solutions.

This collaboration propels BullFrog AI to the forefront of psychiatric research, offering hope for more targeted and effective treatments. As the global demand for mental health solutions rises, this partnership not only demonstrates the potential for scientific advancement but also underscores the economic viability of BullFrog AI’s strategic engagements within the pharmaceutical industry.

January 17, 2024
Ceragon (CRNT) Stock Showcasing A Positive Trajectory Today

Ceragon Networks Ltd. (NASDAQ: CRNT) shares are demonstrating a positive trajectory on US indices today. As of the latest assessment in the current session, Ceragon’s stock exhibits a 6.41% increase, trading at $2.49. This surge in CRNT stock value follows the revelation of a substantial agreement made public earlier today.

In an official statement, Ceragon (CRNT) disclosed the formalization of a strategic alliance with a global integrator, aimed at bolstering a network modernization initiative for a leading Tier-1 Operator in India. As delineated in the agreement, Ceragon will play a pivotal role in supporting an extensive modernization endeavor, concentrating on enhancing existing network capabilities, expanding capacity, elevating nationwide connectivity, and delivering services tailored to meet, if not surpass, the evolving demands of India.

This novel partnership positions CRNT’s latest solutions as the preferred choice for deployment by the aforementioned client. The contractual arrangement, valued at approximately $150 million, encompasses planning, product delivery, and deployment services. Moreover, it includes a multi-year commitment to Ceragon’s Managed Services, encompassing day-to-day monitoring, management, and maintenance oversight of the microwave and millimeter-wave network.

The precise valuation of the agreement may experience fluctuations of up to 25%, contingent upon the actual deployment requirements during the project rollout. Ceragon anticipates commencing the delivery and deployment of new sites in the second quarter of 2024. The deployment phase is slated for completion within 7-9 quarters, with an estimated 75% of the project value anticipated to be realized within this timeframe.

The remaining 25% of the contract value, designated for Managed Services & Maintenance, is expected to commence recognition within a year from deployment, respectively. Ceragon collaborated with a prominent Global Integrator, entrusted with overseeing the multi-billion network modernization project for the Tier-1 Operator. The collaborative efforts ensured alignment with the stringent requirements of the Tier-1 Operator, particularly in the microwave and millimeter-wave solution domain.

All upcoming microwave sites will leverage Ceragon’s novel ultra-compact, energy-efficient all-outdoor radio. Additionally, a multitude of mmW sites will be deployed utilizing CRNT’s E-Band product. The sheer magnitude and comprehensive nature of this initiative further solidify Ceragon’s standing as a renowned and dependable partner in the wireless transport sector, attesting to its innovation and reliability.

January 11, 2024
What Is Fueling The Surge In Transphorm (TGAN) Stock Today

Transphorm, Inc. (NASDAQ: TGAN) shares are making noteworthy strides on the U.S. stock indices today. At the last check during the current session, Transphorm stock has surged by 25.33%, reaching a trading value of $4.75. The impetus behind TGAN’s upward trajectory stems from the revelation of an acquisition bid.

Transphorm (TGAN) formally announced today that it and Renesas Electronics Corporation have entered into a final agreement. A Renesas subsidiary will purchase all outstanding shares of Transphorm’s common stock under the terms of this agreement for $5.10 in cash per share. This amount represents a premium over TGAN’s closing price on January 10, 2024, of almost 35%.

Moreover, it represents a significant 78% premium over the volume-weighted average price in the previous six months and a premium of almost 56% over the volume-weighted average price in the previous twelve months. Transphorm is valued at around $339 million in total in this acquisition.

The acquisition is poised to furnish Renesas with proprietary GaN technology, a pivotal next-generation material for power semiconductors. This strategic move will extend Renesas’ influence into burgeoning markets such as electric vehicles (EVs), computing (encompassing data centers, AI, and infrastructure), renewable energy, industrial power conversion, and fast chargers/adapters.

The surge in demand for highly efficient power systems as foundational components for achieving carbon neutrality underscores a broader industry shift toward wide bandgap (“WBG”) materials, exemplified by silicon carbide (“SiC”) and GaN. These advanced materials afford a more extensive range of voltage and switching frequency compared to traditional silicon-based devices.

Renesas plans to leverage Transphorm’s automotive-qualified GaN technology to pioneer innovative power solutions, including X-in-1 powertrain solutions for EVs, as well as applications in computing, energy, industrial, and consumer domains.

The board of directors at Transphorm has unanimously sanctioned the definitive agreement pertaining to the transaction and has urged Transphorm stockholders to endorse both the agreement and the merger.

In tandem with the agreement’s execution, KKR Phorm Investors L.P., holding approximately 38.6% of Transphorm’s outstanding common stock, has entered into a customary voting agreement with Renesas, committing to vote in favor of the transaction. The anticipated timeline for the transaction’s completion is the second half of the calendar year 2024.

January 11, 2024
What Is Causing A Positive Momentum In SEALSQ (LAES) Stock

SEALSQ Corp (NASDAQ: LAES) has witnessed a notable surge in its stock performance on the US market today, with SEALSQ stock exhibiting a remarkable uptrend of 31.87%, reaching $2.11 at the latest session check. This positive momentum is attributed to the recent introduction of a groundbreaking service by SEALSQ.

In a formal announcement, SEALSQ (LAES) unveiled an expansion of its “on-wafer” semiconductor provisioning offering, introducing a novel “on-Package” chip personalization service with a reduced lead time of just four weeks. This innovative service empowers SEALSQ to provide clients the option to customize off-the-shelf secure elements from its VaultIC range with certificates and keys.

The pre-loaded chips, available in quantities ranging from 1,000 to 20,000 units, can be delivered within a swift four-week timeframe. SEALSQ’s agility in adapting to market demands by swiftly launching new products with accelerated time-to-market aims to cater to the needs of IoT device manufacturers engaged in small-batch production before scaling up.

At the core of SEALSQ’s value proposition is its commitment to being a vertically integrated security provider. This entails the ability to pre-provision its secure element range with private keys and certificates compliant with protocols like MATTER, Wi-SUN, or OPC. This ensures seamless authentication and commissioning, particularly with major cloud platforms such as Microsoft AZURE or AWS Clouds.

Traditionally, chip personalization in the semiconductor industry occurs at an early production stage, involving substantial order volumes and several months of lead time before delivery. SEALSQ disrupts this norm by offering a last-minute personalization service through its VaultITrust personalization platform.

Furthermore, certificate issuance and management are facilitated using SEALSQ’s Managed PKI-as-a-Service platform (INeS). This platform empowers device manufacturers to generate and manage compliant certificates throughout a device’s lifecycle through a user-friendly and potent interface.

SEALSQ’s Provisioning-on-Package service innovation aligns with the industry’s evolution, marked by the release of the Matter specification a year prior. It serves as an exemplary instance of how adherence to standards has rapidly evolved, introducing advanced secure element support with improved speed-to-market. This innovation holds the potential to reduce costs for manufacturers of Smart Home devices.

January 10, 2024
A Drive In EchoStar (SATS) Stock Fueled By Post Merger Moves

EchoStar Corporation (NASDAQ: SATS) shares are experiencing a notable surge in the US market today, marking a substantial 38.11% increase to reach $17.49 as per the latest check during the current trading session. This surge in EchoStar’s stock price can be attributed to a series of strategic maneuvers undertaken subsequent to a recent merger agreement.

Following its merger with DISH Network Corporation (“DISH Network”), EchoStar (SATS) formally announced the successful completion of a series of strategic transactions intended to unleash more strategic, financial, and operational flexibility for the firm. The merger itself was a major union of EchoStar’s premium satellite communication services with DISH Network’s streaming services, countrywide 5G network, and satellite technology. A global leader in terrestrial and non-terrestrial wireless communication was produced as a result of this combination.

The steps revealed today are in line with the broader goal of improving the merged company’s strategic and financial flexibility while simultaneously taking use of the synergies that are inherent in it. DISH Network has given some unencumbered wireless spectrum licenses to EchoStar Wireless Holding L.L.C., a wholly-owned subsidiary of EchoStar, as part of these strategic initiatives. DISH Network will retain ownership of other valuable wireless spectrum licenses.

Following the unrestricting of the DBS Subscriber Subsidiary, it currently boasts around 3.0 million DISH TV subscribers. DISH DBS anticipates continued access to a significant portion of the generated net cash from its pay-TV subscriber base, including those held at DBS Subscriber Subsidiary. This financial flexibility will be utilized for various purposes, such as deleveraging the balance sheet, enhancing the debt maturity profile, and general corporate needs. The broader operations of the DISH Network consolidated business remain unaffected.

This strategic asset allocation positions EchoStar optimally to focus its resources on achieving its goal of becoming the foremost provider of terrestrial mobile, satellite connectivity, and content services. In navigating these complex transactions, the company has enlisted the support of Houlihan Lokey and White & Case LLP, serving as financial and legal advisors, respectively, to evaluate potential strategic alternatives.

January 10, 2024
How Clearmind (CMND) Stock Is Securing A Stronger Position

Currently enjoying a significant upswing on the American stock market, Clearmind Medicine Inc. (NASDAQ: CMND) is in a strong position. As of the most recent update during the current trading session, Clearmind’s stock has experienced a noteworthy 42.03% rise, culminating in a trading value of $2.94. This encouraging trend for CMND shares comes after Clearmind played a crucial role in an important conference.

With great pride, Clearmind (CMND) announces today that its Type A meeting with the US Food and Drug Administration (FDA) has concluded successfully. The company’s clinical study of the patented CMND-100 chemical, based on MEAI, intended to treat Alcohol Use Disorder (AUD) through its novel psychedelic-based therapy, was the main topic of discussion during this conference.

Clearmind confirms that they had an intelligent and fruitful conversation with the FDA recently. The business is now prepared to move forward with U.S. regulatory approval, providing millions of people who are struggling with AUD with a possible ray of hope. The innovative method used by Clearmind seeks to overcome the problems with the available therapy choices.

Concurrently, Clearmind considers its successful partnership with SciSparc in 2023. CMND began the year by submitting six provisional patent applications to the USPTO, which described novel blends of upcoming psychedelic-derived substances. These applications represent a calculated step in Clearmind’s continuing collaboration with clinical-stage pharmaceutical firm SciSparc, which specializes in treating disorders of the central nervous system.

The submitted patent applications are in line with Clearmind’s objective to provide safer and more efficient therapies, enhancing the therapeutic alternatives available to patients suffering from mental health illnesses by growing its portfolio of intellectual property (IP). The goal of this endeavor is to create transformational medications that minimize expenses while providing safety, effectiveness, and synergy.

Any assets resulting from this partnership will be jointly held by Clearmind and SciSparc, in accordance with the collaboration agreement announced on March 8, 2022, demonstrating their continued dedication to delivering cutting-edge solutions in the industry.

January 10, 2024